8-(4-benzenesulfonylamino)quinoline has been researched along with 5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide in 1 studies
| Studies (8-(4-benzenesulfonylamino)quinoline) | Trials (8-(4-benzenesulfonylamino)quinoline) | Recent Studies (post-2010) (8-(4-benzenesulfonylamino)quinoline) | Studies (5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide) | Trials (5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide) | Recent Studies (post-2010) (5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide) |
|---|---|---|---|---|---|
| 15 | 0 | 5 | 7 | 0 | 0 |
| Protein | Taxonomy | 8-(4-benzenesulfonylamino)quinoline (IC50) | 5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide (IC50) |
|---|---|---|---|
| nonstructural protein 1 | Influenza A virus (A/California/07/2009(H1N1)) | 3.626 | |
| kappa-type opioid receptor isoform 1 | Homo sapiens (human) | 1.3 | |
| Vif | Human immunodeficiency virus 1 | 100 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 100 | |
| Transcription factor p65 | Homo sapiens (human) | 1 | |
| Solute carrier family 40 member 1 | Homo sapiens (human) | 2.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auld, DS; Aulner, N; Austin, CP; Branden, L; Cayanis, E; Chung, C; Davis, RE; Deng, S; Gong, G; Huang, W; Inglese, J; Landry, DW; Liu, Y; Pampou, S; Rinderspacher, A; Schürer, S; Smith, DH; Southall, N; Staudt, LM; Thomas, CJ; Többen, U; Vidović, D; Wyler, M; Xie, Y; Zhang, YQ | 1 |
1 other study(ies) available for 8-(4-benzenesulfonylamino)quinoline and 5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide
| Article | Year |
|---|---|
Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation.
Topics: Benzenesulfonamides; Combinatorial Chemistry Techniques; Down-Regulation; NF-kappa B; Quinolines; Structure-Activity Relationship; Sulfonamides | 2008 |